Expeditors International of Wash (NYSE: EXPD) has reported E.P.S. of $1.63 for its third fiscal quarter (ending September 30) versus $1.16 for the same period a year ago — an increase of 41%. E.P.S. were […]
US Physical Therapy Inc (NYSE: USPH) has reported earnings for its third fiscal quarter (ending September 30) of $0.39 versus $0.51 for the same period a year ago — a decline of -24%. For the […]
Qualys Inc (NASDAQ: QLYS) has reported E.P.S. of $1.26 for its third fiscal quarter (ending September 30) versus $1.27 for the same period a year ago — a decline of -1%. E.P.S. were $4.62 for […]
For its third fiscal quarter (ending September 30), Masimo Corp (NASDAQ: MASI) has reported a -10% decline in E.P.S. from $0.20 a year ago to $0.18 in the current quarter. For the latest four quarters […]
For its third fiscal quarter (ending September 30), Bruker Corporation (NASDAQ: BRKR) has reported a -55% decline in E.P.S. from $0.60 a year ago to $0.27 in the current quarter. For the latest four quarters […]
On 11/5/24, Affimed NV (NASDAQ: AFMD) stock enjoyed a major increase of 11.9%, closing at $3.66. Moreover, exceptionally high trading volume at 234% of normal accompanied the advance. Relative to the market the stock has […]
Silicon Laboratories Inc (NASDAQ: SLAB) has reported a loss for its third fiscal quarter (ending September 30) of $-0.88 versus $0.33 for the same period a year ago — a decline of -367%. E.P.S. were […]
For its third fiscal quarter (ending September 30), Semler Scientific Inc (NASDAQ: SMLR) has reported a -2% decline in E.P.S. from $0.82 a year ago to $0.80 in the current quarter. E.P.S. were $2.30 for […]
Medifast Inc. (NYSE: MED) has reported earnings for its third fiscal quarter (ending September 30) of $0.10 versus $2.12 for the same period a year ago — a decline of -95%. For the latest four […]
Illumina Inc (NASDAQ: ILMN) has reported earnings for its third fiscal quarter (ending September 30) of $4.43 versus a loss $-4.77 for the same period a year ago — a decline of -193%. E.P.S. were […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research